Skip to main content

Table 4 Multivariate analysis of clinical features and risk score with Cox proportional hazard model

From: Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma

Covariates Overall survival
HR (95%CI)
p Value
Age (< 65 vs. ≥ 65) 1.418 (0.766–2.625) 0.267
Gender (female vs. male) 0.856 (0.471–1.556) 0.610
BMI (< 25 vs. ≥ 25) 1.495 (0.852–2.623) 0.16
Histological grade
 G1 1  
 G2 1.369 (0.391–4.799) 0.624
 G3 1.836 (0.528–6.383) 0.339
 G4 3.431 (0.695–16.929) 0.130
Clinical stage
 Stage I/II 1  
 Stage III/IV 0.995 (0.127–7.817) 0.996
T stage
 T1/2 1  
 T3/4 2.176 (0.269–17.610) 0.466
AFP (< 300 vs. ≥ 300) 0.902 (0.469–1.736) 0.758
Vascular invasion
 None 1  
 Mico 1.201 (0.616–2.340) 0.590
 Macro 3.322 (1.208–9.141) 0.02
Risk (high vs. low) 2.002 (1.051–3.812) 0.035